SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-23-008695
Filing Date
2023-02-27
Accepted
2023-02-27 06:01:46
Documents
4
Period of Report
2023-03-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20007432x2_def14a.htm DEF 14A 528352
2 logo_statera.jpg GRAPHIC 59986
3 ny20007432x2_pc01.jpg GRAPHIC 676014
4 ny20007432x2_pc02.jpg GRAPHIC 514767
  Complete submission text file 0001140361-23-008695.txt   2251322
Mailing Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526
Business Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526 (888) 613-8802
Statera Biopharma, Inc. (Filer) CIK: 0001318641 (see all company filings)

IRS No.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32954 | Film No.: 23669869
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences